Henk R. van Buuren

Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis

Kirsten Boonstra, Rinse K. Weersma, Karel J. van Erpecum et al. · Hepatology · 2013 · 720 citations · Full text

Medicine, Internal Medicine, Oncology +12

Improved Prognosis of Patients With Primary Biliary Cirrhosis That Have a Biochemical Response to Ursodeoxycholic Acid

Edith M.M. Kuiper, Bettina E. Hansen, Richard A. de Vries et al. · Gastroenterology · 2009 · 460 citations

Medicine, Pathology, Drug Metabolism +13

High lifetime risk of cancer in primary sclerosing cholangitis

Marian M. Claessen, Frank P. Vleggaar, Kristien M.A.J. Tytgat et al. · Journal of Hepatology · 2008 · 416 citations

Medicine, Oncology, Pathology +13

Lysophosphatidic Acid Is a Potential Mediator of Cholestatic Pruritus

Andreas E. Kremer, Job J.W.W. Martens, Wim Kulik et al. · Gastroenterology · 2010 · 406 citations

Life Sciences, Biochemistry, Physiology +9

Genome-Wide Association Study Identifies Variants Associated With Autoimmune Hepatitis Type 1

Ynto S. de Boer, Nicole M. F. van Gerven, Antonie Zwiers et al. · Gastroenterology · 2014 · 306 citations · Full text

Life Sciences, Genetics, Immunology +12